67457-422-54 · Dexamethasone Sodium Phosphate Injection · Mylan Institutional, a Viatris Company
What is the status for 67457-422-54 · Dexamethasone Sodium Phosphate Injection · Mylan Institutional, a Viatris Company?
For 67457-422-54, generic name is Dexamethasone Sodium Phosphate Injection; manufacturer is Mylan Institutional, a Viatris Company; status is Current; availability now is Available; initial posting date is 02/08/2019, recorded from its source on 2026-11-04.
"initial_posting_date": "02/08/2019", "package_ndc": "67457-422-54", "generic_name": "Dexamethasone Sodium Phosphate Injection", "contact_info": "800-796-9526", "availability": "Available"
— api.fda.gov, retrieved 2026-11-04
- Package NDC
- 67457-422-54 verified
- Generic name
- Dexamethasone Sodium Phosphate Injection verified
- Manufacturer
- Mylan Institutional, a Viatris Company verified
- Status
- Current verified
- Availability now
- Available verified
- Initial posting date
- 02/08/2019 verified
- Last update date
- 11/03/2026 verified
- Days in shortage
- 2826 our reading
- Dosage form
- Injection verified
- Therapeutic category
- Dermatology verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Dosage form and Therapeutic category
"update_date": "11/03/2026", "therapeutic_category": [ "Dermatology", "Endocrinology/Metabolism", "Gastroenterology", "Hematology", "Neurology", "Oncology", "Ophthalmology", "Other", "Pulmonary/Allergy", "Rheumatology" ], "dosage_form": "Injection", "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54)", "company_name": "Mylan Institutional, a Viatris Company", "status": "Current"
— all from api.fda.gov, retrieved 2026-11-04
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000